Serum serine and the risk of all-cause mortality: a nested case-control study from the china stroke primary prevention trial (csppt)

HIGHLIGHTS

• who: Xiping Xu from the Case-Control Study From the China Capital Medical University, China have published the article: Serum Serine and the Risk of All-Cause Mortality: A Nested Case-Control Study From the China Stroke Primary Prevention Trial (CSPPT), in the Journal: (JOURNAL) of 19/05/2008
• what: This study provides a key piece of evidence toward the importance of evaluating serum serine levels when assessing the risk of mortality.
• how: The current study was conducted in a Chinese hypertensive population thus whether the observed findings can be extrapolated or applicable . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.